openPR Logo
Press release

Polycystic Ovarian Syndrome Treatment Market - Regional Analysis

08-30-2018 04:11 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Polycystic Ovarian Syndrome Treatment Market - Regional

The organic and inorganic strategies by the market players will boost the polycystic ovarian syndrome treatment market. For instance, in 2016, Millendo Therapeutics, Inc., a biopharmaceutical company, entered into an exclusive license agreement with AstraZeneca for the development and commercialization of phase II entered AZD4901, a candidate product for the treatment of polycystic ovarian syndrome. Moreover, in 2017, Astellas Pharma Inc. completed its acquisition of Ogeda SA (formerly Euroscreen S.A.). The acquisition will expand Astellas’ clinical pipeline with fezolinetant, oral compaound for NK3 receptor target. Fezolinetant was in phase IIa clinical trials for the treatment of menopausal hot flashes, polycystic ovary syndrome (PCOS) and uterine fibroids. Moreover, product approval by various approval bodies will expand the treatment option and in turn leading to the market growth. For instance, in 2014, EffRx Pharmaceuticals SA, got US FDA approval for its proprietary metformin-based product candidate, EX404, for pediatric polycystic ovary syndrome (PCOS).

Increasing funding for research and development of novel treatment will also enhance the polycystic ovarian syndrome treatment market during the forecast period. For instance, in 2017, Bayer and the Society for Reproductive Investigation (SRI) launched of the SRI-Bayer Discovery and Innovation Grants Program for supporting research initiatives for addressing unmet medical needs in women’s health. The grant is dedicated to research in endometriois, uterine fibroids and polycystic ovarian syndrome. Further, grants for the treatment of polycystic ovarian syndrome will fuel the market growth. For instance, in 2017, as part of a multi-year endowment from PCOS Diva, the nonprofit organization PCOS Challenge, Inc. will be offering grants up to $500 to help women and girls struggling with hair and skin issues related to polycystic ovary syndrome (PCOS).

High incidence of polycystic ovarian syndrome is expected to be the key driver for the polycystic ovarian syndrome treatment market. For instance, according to article published in 2014 of Clinical Epidemiology, polycystic ovarian syndrome affects 8 – 20 % of the reproductive-age women, globally. According to World Health Organization, in year 2012 the estimated number of polycystic ovarian syndrome is 116 million worldwide.

Get The Holistic SAMPLE Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1589

Moreover, increasing prevalence of insulin resistance (IR), type 2 diabetes, obesity, and cardiovascular disease fuel the polycystic ovarian syndrome market. According to article published in Lancet, globally, prevalence of overweight and obesity combined has risen by 27.5% for adults between 1980 and 2013. Moreover, according to data by the National Health and Nutrition Examination Survey (NHANES), 2013–2014, in the United States the percentage of obesity is higher in women, i.e. 40 %, than in men, 35%.

Polycystic Ovarian Syndrome Treatment Market – Restrain

The global polycystic ovarian syndrome treatment market growth is hampered by off-labelled and generic drugs present in the market. Moreover, the market is also hindered by the alternated treatment such as used of surgical procedures such as ovarian drilling and laparoscopic drilling.

Regional segmentation of polycystic ovarian syndrome treatment market by Coherent Market Insights, includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America market is expected to emerge as the dominant market for polycystic ovary syndrome treatment market owing to a high diagnosis rate, larger number of local players such as AstraZeneca, Teva etc. and high prevalence of the polycystic ovarian syndrome in the region. Asia Pacific is expected to witness fast growth during the forecast period attributing to high population of risk prone individuals.

Download The PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1589

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Polycystic Ovarian Syndrome Treatment Market - Regional Analysis here

News-ID: 1212806 • Views: 179

More Releases from Coherent Market Insights

Codeine Market 2020 - 2026 | Revenue Opportunies By Top Players Teva Pharmaceuti …
The global Codeine Market research report thoroughly explains each and every aspect related to the Codeine Market, which facilitates the report's reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. The growth trend forecasted on account of thorough examination offers in-depth information regarding the global Codeine Market. A pathway of development is offered by the market to the several connected networks
Memantine Market 2020 - 2026 | In-depth Analysis by Top Players Merz Pharmaceuti …
The global Memantine Market research report thoroughly explains each and every aspect related to the Memantine Market, which facilitates the report's reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. The growth trend forecasted on account of thorough examination offers in-depth information regarding the global Memantine Market. A pathway of development is offered by the market to the several connected networks
Arginine Market 2020 - 2026 | Industry Analysis by Top Players Meihua Holdings G …
The global Arginine Market research report thoroughly explains each and every aspect related to the Arginine Market, which facilitates the report's reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. The growth trend forecasted on account of thorough examination offers in-depth information regarding the global Arginine Market. A pathway of development is offered by the market to the several connected networks
Green UPS Market Global Industry Growth Factors, Top Leaders General Electric Co …
Don't Quarantine Your Research, you keep your social distance and we provide you a social DISCOUNT use QUARANTINEDAYS Code in precise requirement and Get FLAT 1000USD OFF on all CMI reports Restriction of hazardous substance (ROHS) directive adopted by the EU in February 2003 put forth restrictions on the use of certain hazardous chemicals/substances for the manufacturing of electrical or electronic products. The green UPS comply with the directive and is

All 5 Releases


More Releases for PCOS

Global Polycystic Ovary Syndrome (PCOS) Market Research and Forecast 2018-2023
Global polycystic ovary syndrome market size, share, market trends, research and analysis report by diagnosis (ultrasound, pelvic exam, blood test) by treatment (ovarian wedge resection, laparoscopic ovarian drilling, acupuncture) forecast 2018-2023 According to the OMR analysis, the global polycystic ovarian syndrome is growing at a significant rate during 2018-2023. The global polycystic ovarian syndrome has been growing significantly due to initiatives taken by the government authorities regarding early diagnosis of the
Global Polycystic Ovary Syndrome (PCOS) Drugs Market to Reach US$ 1,154.8 Mn by …
According to the latest market report published by Persistence Market Research titled ‘Polycystic Ovary Syndrome Drugs Market: Global Industry Analysis and Forecast, 2016–2024’, the global polycystic ovary syndrome drugs market is expected to register a CAGR of 4.6% during the forecast period 2016–2024 and is expected to expand 1.5x in terms of revenue by 2024. The report analyzes the global PCOS drugs market performance and provides information on key drivers
Global Polycystic Ovary Syndrome (PCOS) Drugs Market to Reach US$ 1,154.8 Mn by …
According to the latest market report published by Persistence Market Research titled ‘Polycystic Ovary Syndrome Drugs Market: Global Industry Analysis and Forecast, 2016–2024’, the global polycystic ovary syndrome drugs market is expected to register a CAGR of 4.6% during the forecast period 2016–2024 and is expected to expand 1.5x in terms of revenue by 2024. The report analyzes the global PCOS drugs market performance and provides information on key drivers
Polycystic Ovary Syndrome (PCOS) Drugs Market 2018: BIOCAD, Merck KGaA, AstraZen …
Qyresearchreports include new market research report “2018-2025 Polycystic Ovary Syndrome (PCOS) Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications” to its huge collection of research reports. The global Polycystic Ovary Syndrome (PCOS) Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017
Polycystic Ovary Syndrome (PCOS) Drugs Market 2018: BIOCAD, Merck KGaA, AstraZen …
Qyresearchreports include new market research report “2018-2025 Polycystic Ovary Syndrome (PCOS) Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications” to its huge collection of research reports. The global Polycystic Ovary Syndrome (PCOS) Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017
Polycystic Ovary Syndrome (PCOS) Treatment Market Presume to Surge at CAGR 4.6% …
According to the latest market report published by Persistence Market Research titled ‘Polycystic Ovary Syndrome Drugs Market: Global Industry Analysis and Forecast, 2016–2024’, the global polycystic ovary syndrome drugs market is expected to register a CAGR of 4.6% during the forecast period 2016–2024 and is expected to expand 1.5x in terms of revenue by 2024. The report analyzes the global PCOS drugs market performance and provides information on key drivers